Sequana Medical NV
XBRU:SEQUA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chongqing Sifang New Material Co Ltd
SSE:605122
|
CN |
|
Shanghai Yongguan Adhesive Products Corp Ltd
SSE:603681
|
CN |
|
Rhoen Klinikum AG
XETRA:RHK
|
DE |
|
Baida Group Co Ltd
SSE:600865
|
CN |
|
Greenwave Technology Solutions Inc
NASDAQ:GWAV
|
US |
|
Orient Green Power Company Ltd
NSE:GREENPOWER
|
IN |
Sequana Medical NV
Cash from Operating Activities
Sequana Medical NV
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sequana Medical NV
XBRU:SEQUA
|
Cash from Operating Activities
-€17.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Nyxoah SA
XBRU:NYXH
|
Cash from Operating Activities
-€69m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Ion Beam Applications SA
XBRU:IBAB
|
Cash from Operating Activities
-€25.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sequana Medical NV
Glance View
Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company is headquartered in Ghent, Oost-Vlaanderen and currently employs 60 full-time employees. The company went IPO on 2019-02-11. The firm focuses mainly on the development of treatment solutions for the management of liver disease, heart failure, malignant ascites and other fluid imbalance disorders. Sequana Medical NV provides alfapump, which is an implantable, programmable, wireless-charged and battery-powered system that is CE-marking for the management of refractory ascites due to liver cirrhosis and malignant ascites. Over 650 alfapump systems have been implanted. Apart from the Alfapump, the Company also aims to develop a direct sodium removal (DSR) therapy, which is a propriety approach to the treatment of volume overload in heart failure.
See Also
What is Sequana Medical NV's Cash from Operating Activities?
Cash from Operating Activities
-17.6m
EUR
Based on the financial report for Jun 30, 2025, Sequana Medical NV's Cash from Operating Activities amounts to -17.6m EUR.
What is Sequana Medical NV's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-3%
Over the last year, the Cash from Operating Activities growth was 30%. The average annual Cash from Operating Activities growth rates for Sequana Medical NV have been 11% over the past three years , -3% over the past five years .
